Editor’s note: Dr. Lee Pickett has retired, but Creators continues to distribute columns from her archive. This one is from 2022. Q: My Lab mix has a mast cell tumor. What can you tell me about this ...
In dogs, mast cell tumors are the most common malignant skin tumors, accounting for approximately 16–21% of all skin cancers. These tumors can appear anywhere on the body but are most frequently found ...
Canine mast cell tumours (MCTs) represent one of the most prevalent neoplasms in dogs, characterised by their markedly heterogeneous clinical behaviour. These tumours, ranging from benign lesions to ...
Cancer Dx expansion and inVue Dx FNA combine preventive screening and rapid, in-clinic diagnosis, enabling veterinarians and pet owners to act with confidence IDEXX Laboratories, Inc. (NASDAQ: IDXX), ...
PRESS RELEASEAB SCIENCE ANNOUNCES THAT THE FDA HAS GRANTED THE STATUS OF MINOR USE IN MAJOR SPECIES DESIGNATION FOR MASIVET IN THE TREATMENT OF ...
Approved Tyrosine Kinase Inhibitor for Metastatic Mast Cell TumorAUSTIN, Texas--(BUSINESS WIRE)--#animalhealth--VMD Sciences, ...
Q: My Lab mix has a mast cell tumor. What can you tell me about this condition? A: A mast cell tumor, or MCT, is the most common form of skin cancer in dogs. Mast cells are white blood cells designed ...
Cancer Dx expansion and inVue Dx FNA combine preventive screening and rapid, in-clinic diagnosis, enabling veterinarians and pet owners to act with confidence Mast Cell Tumors Are Common Mast cell ...
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced two major advancements in veterinary cancer diagnostics: the expansion of its IDEXX Cancer Dx™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results